IARC News

IARC Internal Seminar: Interrogating the architecture of cancer genomes

08/12/2017 Title: Interrogating the architecture of cancer genomes
Speaker: Dr Peter Campbell, Senior Group Leader, Wellcome Trust Sanger Institute, Hinxton, UK
Watch video

Launch of Friends of IARC initiative

07/12/2017 The International Agency for Research on Cancer (IARC) has been a positive force in international public health for more than five decades, focusing on cancer research for cancer prevention. The Friends of IARC initiative is designed to help the Agency continue to fulfil its mission to reduce the global cancer burden. The Friends of IARC serve as ambassadors, testifying to the work and values of the Agency and supporting IARC in reaching out to society and stakeholders. In collaboration with this network of Friends across the world, IARC can achieve even more at this critical time.
View webpage

WHO/IARC signs comprehensive Memorandum of Understanding with the National Cancer Center Japan

05/12/2017 The International Agency for Research on Cancer (IARC) is pleased to announce the extension of its Memorandum of Understanding with the National Cancer Center Japan to expand the scope of joint research and personnel exchanges for research on cancer causes, epidemiology, genomics, early-stage diagnostics, screening, prevention, and survivorship. Read more

IARC's response to the United States House of Representatives Committee on Science, Space, and Technology

30/11/2017 On 20 November 2017, Dr Christopher Wild, Director of the International Agency for Research on Cancer (IARC), responded to a letter from the United States House of Representatives Committee on Science, Space, and Technology raising several points mentioned in some media outlets regarding the evaluation of glyphosate by the IARC Monographs Programme.

Read Response from Dr Wild to the Committee on Science, Space and Technology, 20 November 2017

Read Letter from the Committee on Science, Space and Technology to Dr Wild, 1 November 2017
More information

Publications

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues

07/09/2017 The WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues is a Revised 4th Edition Volume of the WHO series on histological and genetic typing of human tumours. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies monitoring response to therapy and clinical outcome.

This classification, prepared by 132 authors from 23 countries, contains about 1300 colour images and tables, and more than 4500 references.
Read more








Cancer Today

ESTIMATED CANCER
INCIDENCE,
MORTALITY AND PREVALENCE
WORLDWIDE IN 2012

Cancer Today is part of the Global Cancer Observatory website.

FACT SHEETS